Here, siRNA knockdown of TBX2 in two NPC cell lines significantly decreased cancer cell proliferation, which was consistent with previous studies in heart cells [27], in melanoma cells [13] and rhabdomyosarcoma cells [28]. The gene discussed is TBX2; the disease is rhabdomyosarcoma.